Clinical Trials Logo

Macular Hole clinical trials

View clinical trials related to Macular Hole.

Filter by:

NCT ID: NCT01266746 Completed - Macular Hole Clinical Trials

Optical Coherence Tomography in Gas-filled Eyes

Start date: April 2009
Phase: N/A
Study type: Observational

The aim of this study is to determine the condition to detect the status of a macular hole by spectral domain optical coherence tomography (SD-OCT) in gas-filled eyes. The macular area is scanned by SD-OCT (OCT-4000, Carl Zeiss Meditec) in the patients who underwent vitreous surgery for macular hole to detect macular jole closure on postoperative days 1, 3, 7, and 30.

NCT ID: NCT01257698 Completed - Retinal Detachment Clinical Trials

Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy

Start date: February 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to see if glaucoma eye drops (dorzolamide-timolol) have any effect on the duration of an intraocular gas bubble following pars plana vitrectomy.

NCT ID: NCT01083056 Completed - Macular Hole Clinical Trials

Observational Study - ILM Peeling

Start date: March 2010
Phase: N/A
Study type: Observational

This observational study investigates the effects of epimacular membrane peeling on the structure and function of the retina.

NCT ID: NCT01083004 Recruiting - Macular Hole Clinical Trials

Brilliant Blue Versus Indocyanine Green

Start date: January 2008
Phase: Phase 3
Study type: Interventional

A study of non-inferiority design comparing brilliant blue and indocyanine green as intraoperative dye in macular pucker and macular hole.

NCT ID: NCT01069029 Completed - Visual Acuity Clinical Trials

Combined Versus Successive Macular Hole and Cataract Surgery

Start date: January 2006
Phase: N/A
Study type: Observational

The purpose of this study is to compare functional and anatomical results of a combined surgery and two time surgery for macular hole and cataract extraction in one hundred and twenty patients (120 eyes) with idiopathic Macular Hole (MH) and cataract in two academic centers.

NCT ID: NCT00737074 Completed - Clinical trials for Proliferative Diabetic Retinopathy

Macular Hole in Diabetic Retinopathy

Start date: January 2002
Phase: N/A
Study type: Observational

Macular hole in proliferative diabetic retinopathy with fibrovascular proliferation may have unique features. Internal limiting membrane peeling facilitates hole closure only in cases with shallow macular detachment. Final vision is associated with preoperative visual acuity and degree of macula elevation.

NCT ID: NCT00555269 Completed - Macular Hole Clinical Trials

Membrane Blue Versus Infracyanine Green

Start date: October 2004
Phase: N/A
Study type: Observational

To compare possible toxicities of membrane blue and infracyanine green in vivo by macular function and peripheral visual field.

NCT ID: NCT00408720 Completed - Epiretinal Membrane Clinical Trials

Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies

Start date: October 2006
Phase: N/A
Study type: Observational

The purpose of this study is to compare the newly released Spectral OCT/SLO (OTI, Toronto, Canada) with the Zeiss Stratus OCT (Carl-Zeiss Meditec, Dublin, CA) with regards to the quality of the images obtained as well as the ease of use.

NCT ID: NCT00333060 Terminated - Epiretinal Membrane Clinical Trials

Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal

Start date: November 2005
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to compare the ability of two doses of OT-551 ophthalmic solution and drug-free solution to safely and effectively prevent or delay the progression of nuclear cataracts that frequently develop as a result of vitrectomy (surgery for retina repair), thereby avoiding the need for a second surgery (cataract removal). Victrectomies involve removal of the jelly-like substance (vitreous) that is located in a cavity behind the lens.

NCT ID: NCT00190190 Completed - Macular Hole Clinical Trials

Internal Limiting Membrane Peeling for Large Macular Holes

Start date: January 2005
Phase: N/A
Study type: Interventional

Rational of the study: for macular holes larger than 400 µm the rate of failure is of more than 20%. It is for these eyes that it is necessary to show the benefit of internal limiting membrane (ILM) peeling in term of vision and success rate. In order to test the benefit of this gesture, it is necessary to make a randomized study. Primary objective: To show that the percentage of success (anatomical closing, confirmed by OCT) at third postoperative month is higher in the ILM peeling group. Design of the study: Randomized multicentric study, in parallel groups, with individual benefit for the patient. Tested Hypothesis: The success rate of the surgery of idiopathic macular holes larger than 400 µm is increased by the peeling of the MLI. Awaited results: To show that the success rate of the surgery of idiopathic macular holes larger than 400 µm is improved by ILM peeling. This category could then have a success rate similar to the small holes. If this difference is not proven, it will remain no justification to continue this procedure which represents little risk but which is not either without consequence.